OpenAI ↗ · 2026-10-20 08:00 · UTC+8
OpenAI acquires Orchestra Bio
Company news OpenAI Source language: English
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Excerpt
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Short excerpt from the source — open the original for the full text.